News & Updates
Filter by Specialty:
Cathepsin S levels predict survival in NSTE-ACS patients
Circulating cathepsin S (CTSS) is significantly associated with long-term mortality and may be used to enhance risk stratification of patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) over the Global Registry of Acute Coronary Events (GRACE) risk score, suggests a study.
Cathepsin S levels predict survival in NSTE-ACS patients
09 Sep 2022
Slow progress to heart failure, death seen in patients with d-TGA after atrial switch
Most adults with d-loop transposition of the great arteries (d-TGA) after atrial switch operation exhibit slow progression to end-stage heart failure or death, according to a recent study.
Slow progress to heart failure, death seen in patients with d-TGA after atrial switch
09 Sep 2022
Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
A post hoc analysis of the SUSTAIN 6 and PIONEER 6 trials has found that semaglutide reduces incidence of any stroke in people with type 2 diabetes (T2D) at high cardiovascular (CV) risk vs placebo.
Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
09 Sep 2022
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
Hypertensive patients who work shifts face an increased risk of developing more than two cardiometabolic diseases or cardiometabolic multimorbidity, according to a study.
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
08 Sep 2022
Atrial fibrillation in DM tied to end-stage renal disease
Patients with diabetes mellitus (DM) who also have atrial fibrillation (AF) are at a heightened risk of developing end-stage renal disease (ESRD), a recent study has found.
